ABCL logo

AbCellera Biologics (ABCL) Revenue

Annual revenue:

$28.83M-$9.19M(-24.17%)
December 31, 2024

Summary

  • As of today (June 10, 2025), ABCL annual revenue is $28.83 million, with the most recent change of -$9.19 million (-24.17%) on December 31, 2024.
  • During the last 3 years, ABCL annual revenue has fallen by -$346.37 million (-92.32%).
  • ABCL annual revenue is now -94.06% below its all-time high of $485.42 million, reached on December 31, 2022.

Performance

ABCL Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABCLincome statement metrics

Quarterly revenue:

$4.24M-$815.00K(-16.14%)
March 31, 2025

Summary

  • As of today (June 10, 2025), ABCL quarterly revenue is $4.24 million, with the most recent change of -$815.00 thousand (-16.14%) on March 31, 2025.
  • Over the past year, ABCL quarterly revenue has dropped by -$5.72 million (-57.45%).
  • ABCL quarterly revenue is now -98.66% below its all-time high of $316.58 million, reached on March 31, 2022.

Performance

ABCL Quarterly revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABCLincome statement metrics

TTM revenue:

$23.11M-$5.72M(-19.83%)
March 31, 2025

Summary

  • As of today (June 10, 2025), ABCL TTM revenue is $23.11 million, with the most recent change of -$5.72 million (-19.83%) on March 31, 2025.
  • Over the past year, ABCL TTM revenue has dropped by -$12.67 million (-35.41%).
  • ABCL TTM revenue is now -96.17% below its all-time high of $603.21 million, reached on September 30, 2022.

Performance

ABCL TTM revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABCLincome statement metrics

ABCL Revenue Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-24.2%-57.5%-35.4%
3 y3 years-92.3%-98.7%-95.3%
5 y5 years+148.3%-9.1%+194.1%

ABCL Revenue Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-94.1%at low-98.7%at low-96.2%at low
5 y5-year-94.1%+148.3%-98.7%at low-96.2%+194.1%
alltimeall time-94.1%+226.5%-98.7%+32.2%-96.2%+621.7%

ABCL Revenue History

DateAnnualQuarterlyTTM
Mar 2025
-
$4.24M(-16.1%)
$23.11M(-19.8%)
Dec 2024
$28.83M(-24.2%)
$5.05M(-22.4%)
$28.83M(-12.5%)
Sep 2024
-
$6.51M(-11.1%)
$32.96M(-0.3%)
Jun 2024
-
$7.32M(-26.4%)
$33.05M(-7.6%)
Mar 2024
-
$9.95M(+8.4%)
$35.79M(-5.9%)
Dec 2023
$38.02M(-92.2%)
$9.18M(+39.1%)
$38.03M(-24.5%)
Sep 2023
-
$6.60M(-34.4%)
$50.39M(-65.3%)
Jun 2023
-
$10.06M(-17.5%)
$145.18M(-19.8%)
Mar 2023
-
$12.19M(-43.4%)
$181.04M(-62.7%)
Dec 2022
$485.42M
$21.55M(-78.7%)
$485.43M(-19.5%)
Sep 2022
-
$101.38M(+120.8%)
$603.21M(+18.9%)
DateAnnualQuarterlyTTM
Jun 2022
-
$45.92M(-85.5%)
$507.34M(+3.7%)
Mar 2022
-
$316.58M(+127.2%)
$489.06M(+30.3%)
Dec 2021
$375.20M(+60.9%)
$139.33M(+2429.6%)
$375.22M(-15.5%)
Sep 2021
-
$5.51M(-80.1%)
$443.80M(-0.9%)
Jun 2021
-
$27.64M(-86.4%)
$447.65M(+3.8%)
Mar 2021
-
$202.74M(-2.5%)
$431.24M(+85.0%)
Dec 2020
$233.16M(+1907.9%)
$207.91M(+2120.8%)
$233.16M(+719.5%)
Sep 2020
-
$9.36M(-16.6%)
$28.45M(+49.0%)
Jun 2020
-
$11.23M(+141.1%)
$19.09M(+142.9%)
Mar 2020
-
$4.66M(+45.4%)
$7.86M(+145.4%)
Dec 2019
$11.61M(+31.5%)
$3.20M
$3.20M
Dec 2018
$8.83M
-
-

FAQ

  • What is AbCellera Biologics annual revenue?
  • What is the all time high annual revenue for AbCellera Biologics?
  • What is AbCellera Biologics annual revenue year-on-year change?
  • What is AbCellera Biologics quarterly revenue?
  • What is the all time high quarterly revenue for AbCellera Biologics?
  • What is AbCellera Biologics quarterly revenue year-on-year change?
  • What is AbCellera Biologics TTM revenue?
  • What is the all time high TTM revenue for AbCellera Biologics?
  • What is AbCellera Biologics TTM revenue year-on-year change?

What is AbCellera Biologics annual revenue?

The current annual revenue of ABCL is $28.83M

What is the all time high annual revenue for AbCellera Biologics?

AbCellera Biologics all-time high annual revenue is $485.42M

What is AbCellera Biologics annual revenue year-on-year change?

Over the past year, ABCL annual revenue has changed by -$9.19M (-24.17%)

What is AbCellera Biologics quarterly revenue?

The current quarterly revenue of ABCL is $4.24M

What is the all time high quarterly revenue for AbCellera Biologics?

AbCellera Biologics all-time high quarterly revenue is $316.58M

What is AbCellera Biologics quarterly revenue year-on-year change?

Over the past year, ABCL quarterly revenue has changed by -$5.72M (-57.45%)

What is AbCellera Biologics TTM revenue?

The current TTM revenue of ABCL is $23.11M

What is the all time high TTM revenue for AbCellera Biologics?

AbCellera Biologics all-time high TTM revenue is $603.21M

What is AbCellera Biologics TTM revenue year-on-year change?

Over the past year, ABCL TTM revenue has changed by -$12.67M (-35.41%)
On this page